Both in Pharmaceuticals
Pyxis Oncology vs Nkarta
Over the past year PYXS returned −50.8% and NKTX returned −28.3%; their daily moves had a correlation of 0.20.
PYXS −50.8% NKTX −28.3%Growth of $1, one year, split-adjusted
| Metric | PYXS | NKTX |
|---|---|---|
| Price | $1.76 | $1.75 |
| Market cap | $146.8M | $125.3M |
| Today | +4.76% | −2.78% |
| 1 month | −47.1% | −38.2% |
| 6 months | +3.5% | −49.9% |
| Year to date | +53.0% | −5.4% |
| 1 year | −47.5% | −29.7% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 13.3× | — |
| Net cash | $33.0M | $182.8M |
| Dividend yield | — | — |
| Volatility (60d) | 122.1% | 61.6% |
| Short % of float | 8.8% | 8.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).